Received grant in 2017
DCCC has funded 160,000 DKK to the project.
Venous thromboembolism (VTE) causes deterioration of the prognosis for cancer patients. VTE is the most frequent cause of death for cancer patients next to the cancer disease. Use of antithrombotic therapy for the prevention and treatment of VTE should for this reason be equalised with other potential lifesaving and palliating therapy.
The DCCC project will appoint a multidisciplinary working group to document the implementation of the recommendations from the new CAT rapport, identify survival factors as well as factors to increase patient involvement and secure a close collaboration between clinic and research.
Project stakeholders
- Torben Bjerregaard Larsen, Aalborg Thrombosis Research Unit, Aalborg University Hospital. Primary contact, mail: tobl@dcm.aau.dk